Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

EVENITY

ROMOSOZUMAB-AQQG

Standard Dose
105MG/1.17ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview EVENITY is listed in Drugs@FDA under application 761062 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ROMOSOZUMAB-AQQG Form and strength INJECTABLE;INJECTION - 105MG/1.17ML Sponsor AMGEN INC Submission history Latest submission status date: 2019-12-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview EVENITY is listed in Drugs@FDA under application 761062 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ROMOSOZUMAB-AQQG Form and strength INJECTABLE;INJECTION - 105MG/1.17ML Sponsor AMGEN INC Submission history Latest submission status date: 2019-12-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.